Social media set to drive pharma into bright future

8 August 2016
socialmedia-big

Social media is not only being used as a straightforward means of communicatation and marketing, it is also playing an important role in identifying trends, challenges and listening to what patients are talking about.

It gives individuals, communities, businesses and non-government organizations unprecedented connectivity anywhere in the world in real time.

Communications continue to advance at breakneck speed and social media is the digital platform where global conversations are taking place. The number of health apps have grown exponentially, enabling far greater consumer engagement and empowerment.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK

Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight





More Features in Pharmaceutical